Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Lab 3 > Nanomedicines for Protein Delivery > Flashcards

Nanomedicines for Protein Delivery Flashcards

1
Q

What are biopharmaceuticals?

A

drugs made by living cells or organisms to treat diseases, such as monoclonal antibodies and recombinant proteins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the main properties of biopharm/ proteins?

A

high MW >5000 Da
highly water soluble
hydrolysable bonds
large SA 30-50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

diff types?

A

proteins
enz
peptides
nucleic acids
carbs
cell based therapies
vaccines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

barriers to oral administration?

A

enzymatic degradation
acidic environments
transport across the intestinal epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Is oral administration possible for proteins? Why?

A

no:

  • need to overcome 3 barriers that limits their bioavailabulity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the instability problems for biopharmaceutical proteins? 2 types

A

chemical instability: Incompatibility with excipients: hydrolysis, Oxidation

physical instability: proteins are prone to denature, alter their native structure on exposure to heat, extremes of pH or organic solvents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

difference between transcellular and paracellular transport?

A

T: though memb (lipophilic mols)

P: mols pass through tight junctions between cells (hydrophilic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how are proteins administered?

A

parenteral routes - IV/IM/SC
mucosal - oral/nasal/pulmonary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

name intranasal protein administration

A

flu vaccine
calcitonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

name sublingual protein administration

A

desmopressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how are small proteins cleared?

A

glom filtration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how are large proteins cleared? >200nm

A

liver
spleen
lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the immunogenicity risk factors of protein administration?

A

SC, IM >IV
large size
protein aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the least immunogenic risk factors of protein administration?

A

neutral charged proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

protein aggregates provoke what, compromising efficacy of drug?

A

immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can you improve the bioavailability of protein drugs?

A

modify chemical structure
co-administer enzyme inhibitors
PEGylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does PEG affect the characteristics of protein drugs?

A
  • increases proteins M volume abive glom filtration threshold
  • Extends half-life
  • Reduces immunogenicity- stealth effect!!
  • Prevents premature degradation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Advantanges of using protein nanodrugs for nasal and pulmonary delivery?

A
  1. low proteolytic activity compared to GI tract
  2. strong immune responses
  3. lower doses of drug required
  4. nasal route - delivery to the brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Disadvantanges of using protein nanodrugs for nasal and pulmonary delivery?

A
  1. epithelium is firmly closed by tight functions - transcellular
  2. loose epithelium, no mucus barrier - paracellular only
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the main barrier to nasal and pulmonary delivery?

A

airway epithelium is firmly closes by tight junctions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What drugs are suitable for transdermal route?

A

Small hydrophobic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what must proteins administered via transdermal route do?

A

i) penetrate through corneocytes and intervening lipids (intracellular transport) or
ii) pass between corneocytes (intercellular transport) or
iii) be transported across skin appendages such as hair follicles and sebaceous glands (skin appendageal transport) to reach target sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what are the adv/disadv of therapeutic protein drugs?

A

Advantages:
- high specificity, great activity, and low toxicity

Barriers:
- vulnerable structure, susceptibility to enzymatic degradation, short circulation half-lives, and poor membrane permeability, stability issues, immunogenicity, inefficient membrane permeability and endosomal escape issues
- Development of effective protein delivery strategies is therefore essential to further enhance therapeutic outcomes to enable widespread medical applications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

2 types of targeting w NPs?

A

passive: EPR effect

active: receptor-ligand ints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
how are nanoparticle technologies used to deliver protein?
i) protect proteins from premature degradation or denaturation in biological environment ii) enhance systemic circulation half-life of proteins with poor pharmacokinetic properties iii) control sustained and/or tunable release which can maintain drug concentration in the therapeutic range iv) target diseased tissues, cells, and subcellular organelles/ intracellular compartments, thus improving drug efficacy, mitigate adverse off-target effects and potentially lower the required dose for desired effect of biologic therapeutics
26
main issue w NPs: aggregates, why?
minimise surface charge + energy triger opsonisation MPS clears them after recognising :(
27
why do you get increase NP aggregation in blood?
complex, highly ionic nature
28
T/F: smaller liposomes <200nm are clared more slowly that larger?
true
29
what surface charge allows slower clearance/ better ability to avoid opsonisation and MPS?
neutral!
30
how does PEG have a longer half-life ?
increased systemic circulation due to evading mononuclear phagocytic system (MPS)
31
how does PEG evade mononuclear phagocytic system (MPS)?
neutral surface charge = avoids opsonisation reduces non-specific adsorption of opsonin-stealth properties
32
what is active targeting used for in NPs?
facilitate drug transport
33
name active targeting agents used in NPs
cell-penetrating peptides (CPP) - argine-rich peptides - amphiphilic peptide carriers - Pep-1 = cell permeable sequence
34
how do cell-penetrating peptides work ? different methods
direct penetration endocytosis-mediated uptake translocation via transitory structure formation = improve intracellular protein delivery
35
what are the 3 barriers for creating NPs?
organic solvents to make = denatures proteins/harm biological activity low loading efficiency drug release - controlled release needed
36
name the types of proteins delivered?
polymeric inorganic lipid-based
37
name examples of polymeric proteins delivered?
polymersome dendrimer polymer micelle nanosphere
38
name examples of inorganic proteins delivered?
silica NP quantum dot iron oxide NP gold NP
39
name examples of lipid-based proteins delivered?
liposome lipid NP emulsion
40
what must be added to inorganic proteins? and why?
a linker attached to the surface - mask properties of the protein/peptide - surface charge and linker must degrade at site of action
41
name an example of polymeric NPs
poly(lactic-co-glycolic acid) P
42
why is poly(lactic-co-glycolic acid)/PLGA used? polymeric NPs
biocompatible biodegradable with favourable degradation rates
43
what are the advantages of polymeric NPs?
Biodegradable, water soluble, biocompatible, stable, and surfaces modification
44
what are the disadvantages of polymeric NPs?
particle aggregation, toxicity Only a small number of polymeric nanomedicines are currently FDA approved and used in the clinic Proteins release by both diffusion from the polymer matrix and the degradation/erosion of the polymer
45
how are polymeric NPs released?
by both diffusion from the polymer matrix and the degradation/erosion of the polymer
46
name an example of inorganic NPs
mesoporous silica NP
47
describe mesoporous silica NP (inorganic NPs)
inert non-immunogenic modifiable therapeutic agents
48
what are the disadvantages of using lipid-based NPs
stability issues encapsulation efficacy release profiles
49
classical eg of lipid based NPs?
liposomes
50
what are virosomes
lipid-based NPs drug delivery systems based on unilamellar phospholipid membrane which incorporate virus-derived proteins eg Epaxel
51
disadvantages of lipid based NPs?
have to use organic solvents in prep = not ideal for proteins low loading efficacy esp smaller liposomes
52
how does drug release for lipid based NPs occur?
through diffusion - membrane or by dissociation of lipid
53
what are stimuli-responsive liposomes?
smart liposomes control drug release at site of action by lipid dissociation and simple diffusion
54
what stimuli activate stimuli-responsive liposomes?
temperature pH enzyme redox light
55
2 types of stimuli responsive liposomes?
pH responsive thermosensitive TSL
56
how do thermosensitive liposomes work (TSL)?
contain phospholipids with phase transition temperature (Tm) slightly above the physiological temperature eg DPPC - Tm 41degrees
57
what are alternative nanocarriers for protein delivery?
polymer network polymersomes polymer micelles nano/micro emulsions solid lipid exosomes micelles niosomes
58
how do polymer network deliver proteins?
contains alot of H2O protein loading/release: swelling and degradability
59
example of polymer network?
insulin loaded chitosan-based hydrogel NPs
60
Advantages of polymer networks as protein DDS?
- stealth character- guarantee extended plasma half-life - due to hydrophilic polymers - Enhanced targeting- control polymer composition
61
Disadvantages of polymer networks as protein DDS?
the interference of the polymer with protein activity - due to steric hinderance
62
how are polymersomes made?
block/graft of amphiphilic copolymers with low MW PEG = hydrophilic core have similar properties to those of liposomes
63
Advantages of polymersomes?
higher membrane stability than liposomes. controlled size, shape and membrane thickness, mechanical strength, surface chemistry
64
Disadvantages of polymersomes?
- poor encapsulation efficiency (<5% for BSA and Hb) (3) - membrane thickness - thermodynamic/kinetic barrier
65
name examples of polymersomes
poly ethylene glycol-poly propylene sulfide block copolymers and low MW PEG polymersomes
66
how are polymeric micelles made?
amphiphilic block copolymers = hydrophobic core low micellar composition = low drug dissolution when injected into the blood = increase stability low CMCs
67
Advantages of polymeric micelles ?
- more stable than surfactant-based micelles - slow kinetics of dissociation: IV administration do not cause immediate dissolution
68
Disadvantages of polymeric micelles ?
- Limited encapsulation due to hydrophobic core - Ionic-hydrophilic block copolymers - polyionic complex micelles for proteins via electrostatic interactions
69
what are nanoemulsions made out of?
Colloidal dispersions composed of oil, water and surfactants (1, 2) o/w OR w/o microemulsion and nanoemulsions
70
Advantages of protein delivery by nanoemulsion?
- high encapsulation efficiency - Cheap process, can easily be scaled up
71
Disadvantages of protein delivery by nanoemulsion?
use organic solvents, and high mechanical forces: pressure and temperatures
71
SLNs (term 1)
72
what are exosomes made out of?
lipid bilayer neutral extracellular vesicles w native membrane composition
73
Advantages of using exosomes for protein drug delivery?
- Safe- minimal toxicity - immunocompatibility - High biocompatibility
74
disadvantages of using exosomes for protein drug delivery?
- Complex preparative and purification methods needed
75
what are niosomes made out of?
non-ionic surfactant vesicles (10-20um) with non-ionic surfactants and cholesterol
76
Advantages of niosomes for protein drug delivery?
Biocompatibility Low toxicity Ease of preparation
77
Disdvantages of niosomes for protein drug delivery?
Physical instability as they can aggregate or fuse between themselves.
78
what are protein-based nanomaterials made of?
hollow protein NPs comprised of virus capsids, virus-like particles, ferritin, heat shock proteins, chaperonins.... formed by self assembly of protein subunits
79
carrier and drug in protein based nanomaterial made of..
same aa building blocks
80
advantages of protein based NPs as protein carrier?
Optimally sized for endocytosis Nontoxic Biocompatible Biodegradable
81
disadvantages of protein based NPs as protein carrier?
Lack of reproducibility

Lab 3 (21 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions